Outcomes of catheter-directed versus systemic thrombolysis for the treatment of pulmonary embolism: A real-world analysis of national administrative claims.
Document Type
Article
Publication Date
8-1-2020
Institution/Department
Internal Medicine; Cardiology; Critical Care
Journal Title
Vascular medicine (London, England)
MeSH Headings
Administrative Claims, Healthcare, Adult, Aged, Comparative Effectiveness Research, Databases, Factual, Female, Fibrinolytic Agents, Hemorrhage, Hospital Mortality, Humans, Male, Middle Aged, Pulmonary Embolism, Retrospective Studies, Risk Assessment, Risk Factors, Thrombolytic Therapy, Time Factors, Treatment Outcome, United States
Abstract
Catheter-directed thrombolysis (CDT) and systemic thrombolysis (ST) are used to treat intermediate/high-risk pulmonary embolism (PE) in the absence of comparative safety and effectiveness data. We utilized a large administrative database to perform a comparative safety and effectiveness analysis of catheter-directed versus systemic thrombolysis. From the Optum
ISSN
1477-0377
First Page
334
Last Page
340
Recommended Citation
Geller, Bram J; Adusumalli, Srinath; Pugliese, Steven C; Khatana, Sameed Ahmed M; Nathan, Ashwin; Weinberg, Ido; Jaff, Michael R; Kobayashi, Taisei; Mazurek, Jeremy A; Khandhar, Sameer; Yang, Lin; Groeneveld, Peter W; and Giri, Jay S, "Outcomes of catheter-directed versus systemic thrombolysis for the treatment of pulmonary embolism: A real-world analysis of national administrative claims." (2020). MaineHealth Maine Medical Center. 1910.
https://knowledgeconnection.mainehealth.org/mmc/1910